Introduction to the Symposium on bistable and sensitizing pigments in vision

P. Hillman

DOI: https://doi.org/10.1007/BF00535441

Biophysics of Structure and Mechanism

Abstract:

What problem does this paper attempt to address?

The Protective Role Of Neuregulin1-Erbb4 Signaling In A Chronic Social Defeat Stress Model

Wenjuan Wang,Yong Qiao,Huiying Qu,Lin Zhu,Linlin Mu,Chunyue Li,Jie Fang,Hong Lian

DOI: https://doi.org/10.1097/WNR.0000000000001464

2020-01-01

Neuroreport

Abstract:Major depressive disorder (MDD) is a highly prevalent debilitating psychiatric disease and a serious public health problem worldwide. Brain structural MRI and postmortem studies on patients with depression have revealed changes in the anatomy and functionality in various brain regions, including the amygdala, thalamus, hippocampus, and prefrontal cortex (PFC). The alterations in these brain regions could be a result, in part, of the dysregulation of the neurotrophic factors. Neuregulin1 (NRG1) is one of the neurotrophic factors, and our previous study showed that the NRG1-ErbB4 signaling pathway plays a critical role in epilepsy. In this study, we established a chronic social defeat stress (CSDS) model to investigate the role of the NRG1-ErbB4 signaling pathway in depression-like behaviors. In CSDS mice, we found that the NRG1 protein expression levels were significantly decreased both in the medial prefrontal cortex (mPFC) and hippocampus, while phosphorylated ErbB4 only decreased in the mPFC. In addition, lateral ventricle NRG1 administration significantly rescued depression-like behaviors in the susceptible group. The current study suggests that the NRG1-ErbB4 signaling pathway may exert a protective role in MDD.
Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Lishu Gao,Yue Gao,Enping Xu,Jian Xie

DOI: https://doi.org/10.4306/pi.2015.12.3.388

2015-01-01

Psychiatry Investigation

Abstract:OBJECTIVE:Major depressive disorder (MDD) is a common mood disorder associated with several psychophysiological changes like disturbances of sleep, appetite, or sexual desire, and it affects the patients' life seriously. We aimed to explore a genetic method to investigate the mechanism of MDD.METHODS:The mRNA expression profile (GSE53987) of MDD was downloaded from Gene Expression Omnibus database, including 105 samples of three brain regions in post-mortem tissue suffered from MDD and unaffected controls. Differentially expressed genes (DEGs) in MDD were identified using the Limma package in R. Gene Ontology functions and Kyoto Enrichment of Genes and Genomes pathways of the selected DEGs were enriched using Database for Annotation, Visualization and Integrated Discovery. Protein-protein interactive network of DEGs was constructed using the Cytoscape software.RESULTS:Totally, 241 DEGs in MDD-hip group, 218 DEGs in MDD-pfc group, and 327 DEGs in MDD-str group were identified. Also, different kinds of biological processes of DEGs in each group were enriched. Besides, glycan biosynthesis of DEGs in MDD-str group, RIG-I-like receptor signaling and pyrimidine metabolism of DEGs in the MDD-hip group were enriched, respectively. Moreover, several DEGs like PTK2, TDG and CETN2 in MDD-str group, DCT, AR and GNRHR in MDD-pfc group, and AKT1 and IRAK1 in MDD-hip group were selected from PPI network.CONCLUSION:Our data suggests that the brain striatum tissue may be greatly affected by MDD, and DEGs like PTK2, GALNT2 and GALNT2 in striatum, AR in prefrontal cortex and IRAK1 and IL12A in hippocampus may provide novel therapeutic basis for MDD treatment.
Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).

Ashley B. Wentworth,J. Yiannias,J. Keeling,Matthew R Hall,M. Camilleri,L. A. Drage,R. Torgerson,Debra D. Fett,Amy V. Prakash,L. Scalf,E. M. Allen,J. Johnson,Nidhi Singh,Diane L Nordberg Linehan,J. Killian

DOI: https://doi.org/10.1016/j.jaad.2013.09.047

2014-02-01

Abstract:
Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

Yexiang Chen,Yunhao Jiang,Xingcong Jiang,Caiyu Zhai,Yifei Wang,Chi Xu

DOI: https://doi.org/10.3389/fphar.2024.1472468

IF: 5.6

2024-10-15

Frontiers in Pharmacology

Abstract:Introduction: Major depressive disorder (MDD), characterized by severe neuropsychiatric symptoms and significant cognitive deficits, continues to present both etiological and therapeutic challenges. However, the specific underlying mechanisms and therapeutic targets remain unclear. Methods: We analyzed human postmortem dorsolateral prefrontal cortex (dlPFC) samples from MDD patients using datasets GSE53987 and GSE54568, identifying three key genes: AGA, FBXO38, and RGS5. To model depressive-like behavior, we employed chronic social defeat stress (CSDS) and subsequently measured the expression of AGA, FBXO38, and RGS5 in the dlPFC using qPCR and Western blot analysis following CSDS exposure. Results: CSDS significantly induced depressive-like behavior, and both the protein and transcriptional expression levels of AGA, FBXO38, and RGS5 in the dlPFC of mice were markedly reduced after stress, consistent with findings from datasets GSE53987 and GSE54568. Conclusion: Our research suggests that AGA, FBXO38, and RGS5 are potential biomarkers for MDD and could serve as valuable targets for MDD risk prediction.

pharmacology & pharmacy
Identification of Major Depressive Disorder Disease-Related Genes and Functional Pathways Based on System Dynamic Changes of Network Connectivity.

Ruijie Geng,Xiao Huang

DOI: https://doi.org/10.1186/s12920-021-00908-z

2021-01-01

BMC Medical Genomics

Abstract:Background Major depressive disorder (MDD) is a leading psychiatric disorder that involves complex abnormal biological functions and neural networks. This study aimed to compare the changes in the network connectivity of different brain tissues under different pathological conditions, analyzed the biological pathways and genes that are significantly related to disease progression, and further predicted the potential therapeutic drug targets. Methods Expression of differentially expressed genes (DEGs) were analyzed with postmortem cingulate cortex (ACC) and prefrontal cortex (PFC) mRNA expression profile datasets downloaded from the Gene Expression Omnibus (GEO) database, including 76 MDD patients and 76 healthy subjects in ACC and 63 MDD patients and 63 healthy subjects in PFC. The co-expression network construction was based on system network analysis. The function of the genes was annotated by Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Human Protein Reference Database (HPRD, http://www.hprd.org/ ) was used for gene interaction relationship mapping. Results We filtered 586 DEGs in ACC and 616 DEGs in PFC for further analysis. By constructing the co-expression network, we found that the gene connectivity was significantly reduced under disease conditions ( P = 0.04 in PFC and P = 1.227e−09 in ACC). Crosstalk analysis showed that CD19, PTDSS2 and NDST2 were significantly differentially expressed in ACC and PFC of MDD patients. Among them, CD19 and PTDSS2 have been targeted by several drugs in the Drugbank database. KEGG pathway analysis demonstrated that the function of CD19 and PTDSS2 were enriched with the pathway of Glycerophospholipid metabolism and T cell receptor signaling pathway. Conclusion Co-expression network and tissue comparing analysis can identify signaling pathways and cross talk genes related to MDD, which may provide novel insight for understanding the molecular mechanisms of MDD.
Transcriptome comparative analysis of amygdala-hippocampus in depression: A rat model induced by chronic unpredictable mild stress (CUMS)

Shu Yang,Li Yi,Xiaodi Xia,Xiaolu Chen,Xiao Hou,Longjie Zhang,Fang Yang,Jiaxin Liao,Zhijie Han,Yixiao Fu

DOI: https://doi.org/10.1016/j.jad.2023.04.074

IF: 6.533

2023-04-27

Journal of Affective Disorders

Abstract:Background Depression is a common and complex mental disease, and its pathogenesis involves several brain regions. Abnormalities in the amygdala-hippocampal neural circuits have been shown to be involved in depression. However, the underlying molecular mechanisms remain unclear. Methods A rat model was used to determine the transcriptome changes in the amygdala-hippocampal neural network under chronic unpredictable mild stress (CUMS). Depression-related modules in this neural network were identified using weighted gene co-expression network analysis (WGCNA). Difference and enrichment analyses were used to determine differential gene expression in the two brain regions. Results The modules in the amygdala and hippocampus associated with depression-like behavior contained 363 and 225 genes, respectively. Forty-two differentially expressed genes were identified in the amygdala candidate module and 37 in the hippocampus. Enrichment analysis showed that candidate genes in the amygdala were associated with neuronal myelination and candidate genes in the hippocampus were associated with synaptic transmission. Finally, based on module hub gene statistics, differential gene expression, and protein-protein interaction networks, 11 central genes were found in the amygdala candidate module, and one central gene was found in the hippocampal module. Limitations Our study was based on a rat CUMS model. Further evidence is needed to prove that our results are applicable to patients with depression. Conclusion This study identified critical modules and central genes involved in the amygdala-hippocampal circuit in the context of depression, and may provide further understanding of the pathogenesis of depression and help identify potential targets for antidepressant therapy.

psychiatry,clinical neurology
Identification of Key Genes and the Pathophysiology Associated with Major Depressive Disorder Patients Based on Integrated Bioinformatics Analysis

Guangyin Zhang,Shixin Xu,Zhenqing Zhang,Yu Zhang,Yankun Wu,Jing An,Jinyu Lin,Zhuo Yuan,Li Shen,Tianmei Si

DOI: https://doi.org/10.3389/fpsyt.2020.00192

IF: 4.7

2020-01-01

Frontiers in Psychiatry

Abstract:Background: At present, laboratory blood tests to support major depressive disorder (MDD) diagnosis are not available. This study aimed to screen potential mRNAs for peripheral blood biomarkers and novel pathophysiology of MDD. Methods: The present study utilized public data from two mRNA microarray datasets to analyze the hub genes changes related to MDD. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially expressed genes (DEGs) were performed. Finally, some potential mRNA quality biomarkers for hub gene expression in blood were identified. Results: A total of 25 significantly co-upregulated DEGs and 98 co-downregulated DEGs were obtained from two datasets. The pathway enrichment analyses showed that co-upregulated genes were significantly enriched in the regulation of cell-matrix adhesion and mitochondrial membrane permeability which were involved in the apoptotic process. Co-downregulated genes were mainly involved in the neutrophil activation which in turn was involved in the immune response, degranulation and cell-mediated immunity, positive regulation of immune response, the Toll-like receptor signaling pathway, and the NOD-like receptor signaling pathway. From the PPI network, 14 hub genes were obtained. Among them, the subnetworks of PLCG1, BCL2A1, TLR8, FADD, and TLR4 screened out from our study have been shown to play a role in immune and inflammation responses. Discussion: The potential molecular mechanisms that have been identified simultaneously include innate immunity, neuroinflammation, and neurotrophic factors for synapse function and development.
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.

Sujani G. Surakanti,M. Agulnik

DOI: https://doi.org/10.1053/j.seminoncol.2008.03.009

IF: 5.385

2008-06-01

Seminars in Oncology

Abstract:Salivary gland tumors are a rare and clinically diverse group of neoplasms that represent less than 1% of all malignancies. In locoregional recurrent or metastatic disease, systemic therapy is the standard approach. Numerous phase II studies with small sample sizes have assessed the activity of different cytotoxic agents, either alone or in combination. For these agents, the objective response rates are generally modest, ranging from 15% to 50%. Duration of response is typically cited in the range of 6 to 9 months. Further evaluation of novel therapies is mandated in this disease. With the emergence of molecular targeted therapy, these tumors become optimal candidates for trials of investigational drugs and established drugs for new indications. Often, salivary gland carcinomas are indolent. As such, one should wish only to treat patients with progressive disease. Study designs must incorporate stringent inclusion criteria to enable accurate reporting of disease response and stabilization, especially in the evaluation of new drugs and novel combinations. Salivary gland-focused cooperative groups are necessary in order to accrue patients to these clinical trials and establish new treatment guidelines for these patients.
Identification and Analyses of Crucial Genes Associated with Pathogenesis of Major Depressive Disorder

Jiao Li,Qing Ma,Ming Ai

DOI: https://doi.org/10.5152/pcp.2023.22488

2023-12-01

Abstract:Background: Major depressive disorder is a debilitating mental condition that causes severe disability leading to a high fatality rate. No valid blood-based biomarkers for major depressive disorder are currently available. The purpose of this research is to investigate gene biomarkers and pathways that may be linked to major depressive disorder pathogenesis. Methods: Two microarray databases were retrieved from Gene Expression Omnibus for screening of candidate differentially expressed genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed followed by protein-protein interaction network of differentially expressed genes. Results: About 1181 differentially expressed genes were identified from the microarray databases. Gene Ontology analyses indicated that these differentially expressed genes were significantly enriched in mRNA splicing via spliceosome, neutrophil degranulation, peptide antigen assembly with MHC class II protein complex, and immunoglobulin production-mediated immune response. The most enriched Kyoto Encyclopedia of Genes and Genomes pathway terms of the 10 significant were Hematopoietic cell lineage. About 20 genes were identified as hub genes after pathway analyses, mostly involved in colorectal cancer and the composition of ribosomes and protein processing, including KRAS, CD86, RPL9, RPL3, and RPL18. Conclusion: New candidate genes have been identified using bioinformatic approaches that suggest their involvement in the pathogenesis of major depressive disorder and serve as potential genetic diagnostic markers as well as new therapeutic targets.
NMR stray-field analysis of oil drop size distribution in peanut cotyledons

K. J. Carlton,M. R. Halse,A. M. Maphossa,M. Mallett

DOI: https://doi.org/10.1007/s002490000098

European Biophysics Journal

Abstract:
Comprehensive analysis of endoplasmic reticulum stress and immune infiltration in major depressive disorder

Jing Zhang,Shujun Xie,Yujia Chen,Xin Zhou,Zhuanfang Zheng,Lingling Yang,Yan Li

DOI: https://doi.org/10.3389/fpsyt.2022.1008124

IF: 4.7

2022-10-25

Frontiers in Psychiatry

Abstract:Background: Major depressive disorder (MDD) is a life-threatening, debilitating mental health condition. An important factor in the development of depression is endoplasmic reticulum stress (ERS). However, their roles in MDD have not yet been established. The goal of this study was to examine ERS and its underlying molecular mechanisms in MDD. Methods: We used data from two microarray datasets (GSE98793 and GSE39653) and the GeneCards database to examine the reticulum stress-related differentially expressed genes (ERSR-DEGs) associated with MDD. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and Gene Set Variation Analysis (GSVA) were used to further investigate the function and mechanism of ERS in MDD. Moreover, we constructed protein-protein interaction (PPI) networks to identify hub genes as well as the regulatory network of microRNAs (miRNAs), transcription factors (TFs), and potential drugs related to ERSR-DEGs. CIBERSORT was then used to evaluate the immune activity of MDD samples and conduct a correlation analysis between the hub genes and immune cells. Results: In total, 37 ERSR-DEGs and five hub genes were identified (NCF1, MAPK14, CASP1, CYBA, and TNF). Functional enrichment analysis revealed that ERSR-DEGs were predominantly enriched in inflammation-and immunity-related pathways, such as tumor necrosis factor signaling, NF-κB signaling, and Toll-like receptor signaling pathways. Additionally, 179 miRNAs, 25 TFs, and 15 potential drugs were tested for their interactions with the ERSR-DEGs. CIBERSORT found high proportions of Tregs, monocytes, and macrophages M0 in the MDD samples. Among these, hub genes showed a significant correlation with immune cell infiltration in patients with MDD. Conclusions: NCF1, MAPK14, CASP1, CYBA, and TNF are potential ERS-related biomarkers for the diagnosis of MDD. Our research has revealed a significant correlation between immune cells and ERS-related genes with MDD. Not only did our study contribute to a better understanding of the regulatory mechanisms of ERS in underlying MDD pathology, but it also established a paradigm for future studies on ERS.

psychiatry
Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex

Ke Ma,Li Guo,Aiping Xu,Shan Cui,Jin-Hui Wang

DOI: https://doi.org/10.1371/journal.pone.0159093

IF: 3.7

2016-07-18

PLoS ONE

Abstract:BACKGROUND: Major depression is a prevalent mood disorder. Chronic stress is presumably main etiology that leads to the neuron and synapse atrophies in the limbic system. However, the intermediate molecules from stresses to neuronal atrophy remain elusive, which we have studied in the medial prefrontal cortices from depression mice.METHODS AND RESULTS: The mice were treated by the chronic unpredictable mild stress (CUMS) until they expressed depression-like behaviors confirmed by the tests of sucrose preference, forced swimming and Y-maze. High-throughput sequencings of microRNA and mRNA in the medial prefrontal cortices were performed in CUMS-induced depression mice versus control mice to demonstrate the molecular profiles of major depression. In the medial prefrontal cortices of depression-like mice, the levels of mRNAs that translated the proteins for the GABAergic synapses, dopaminergic synapses, myelination, synaptic vesicle cycle and neuronal growth were downregulated. miRNAs of regulating these mRNAs are upregulated.CONCLUSION: The deteriorations of GABAergic and dopaminergic synapses as well as axonal growth are associated with CUMS-induced depression.

multidisciplinary sciences
Comparative transcriptional analyses of the striatum in the chronic social defeat stress model in C57BL/6J male mice and the gut microbiota-dysbiosis model in Kumming mice

Weiyi Chen,Yiyun Liu,Juncai Pu,Siwen Gui,Dongfang Wang,Xiaogang Zhong,Wei Tao,Xiaopeng Chen,Xiang Chen,Yue Chen,Libo Zhao,Qingyuan Wu,Xiangyu Chen,Yingying Zhang,Anmu Xie,Peng Xie

DOI: https://doi.org/10.1016/j.neuroscience.2024.10.057

IF: 3.708

2024-11-04

Neuroscience

Abstract:Depression is a complex disorder with multiple contributing factors, and chronic stress has previously been recognized as a major causative factor, while gut microbes have also been found to be involved in depression recently. However, gene expression in depression models with different etiologies is unclear. Here, we compared the transcriptomes of the striatum in chronic social defeat stress (CSDS) model of C57BL/6J male mice and fecal microbiota transplant (FMT) model of Kumming male mice. We found that the proportion of shared differentially expressed genes (DEGs) between the two models was only 24 %. The specific DEGs of FMT model were enriched in immune and inflammatory, and are associated with changes in vascular and ciliated ependymal cells. The specific DEGs of CSDS model were enriched in neuron and synapse. The results of network analysis suggested the expression patterns and biological function of depressive-like behaviors-related modules in the two models are different. Further, the alternative splicing events of CSDS are more than FMT. Our results suggested models of depression induced by different etiologies differ significantly in gene expression and biological function. Our study also suggested us to pay attention to the characteristics of models of depression of different etiologies and provided a more comprehensive understanding of the heterogeneity of depression.

neurosciences
Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis

Hye In Woo,Shinn-Won Lim,Woojae Myung,Doh Kwan Kim,Soo-Youn Lee

DOI: https://doi.org/10.1038/s12276-018-0123-0

2018-08-01

Abstract:Abstract Treatment response to antidepressants is limited and varies among patients with major depressive disorder (MDD). To discover genes and mechanisms related to the pathophysiology of MDD and antidepressant treatment response, we performed gene expression analyses using peripheral blood specimens from 38 MDD patients and 14 healthy individuals at baseline and at 6 weeks after the initiation of either selective serotonin reuptake inhibitor (SSRI) or mirtazapine treatment. The results were compared with results from public microarray data. Seven differentially expressed genes (DEGs) between MDD patients and controls were identified in our study and in the public microarray data: CD58 , CXCL8 , EGF , TARP , TNFSF4 , ZNF583 , and ZNF587 . CXCL8 was among the top 10 downregulated genes in both studies. Eight genes related to SSRI responsiveness, including BTNL8 , showed alterations in gene expression in MDD. The expression of the FCRL6 gene differed between SSRI responders and nonresponders and changed after SSRI treatment compared to baseline. In evaluating the response to mirtazapine, 21 DEGs were identified when comparing MDD patients and controls and responders and nonresponders. These findings suggest that the pathophysiology of MDD and treatment response to antidepressants are associated with a number of processes, including DNA damage and apoptosis, that can be induced by immune activation and inflammation.

biochemistry & molecular biology,medicine, research & experimental
Entorhinal cortex-based metabolic profiling of chronic restraint stress mice model of depression

Xi Chen,Tianlan Lan,Yue Wang,Yong He,Zhonghao Wu,Yu Tian,Yan Li,Mengge Bai,Wei Zhou,Hanping Zhang,Ke Cheng,Peng Xie

DOI: https://doi.org/10.18632/aging.102798

2020-02-12

Abstract:Despite that millions of people suffer from major depressive disorder (MDD), the mechanism underlying MDD remains elusive. Recently, it has been reported that entorhinal cortex (EC) functions on the regulation of depressive-like phenotype relying on the stimulation of glutamatergic afferent from EC to hippocampus. Based on this, we used liquid chromatography-tandem mass spectrometry method to explore metabolic alterations in the EC of mice after exposed to chronic restraint stress (CRS). Molecular validation was conducted via the application of western blot and RT-qPCR. Through this study, we found significant upregulation of glutamate, ornithine aspartic acid, 5-hydroxytryptophan, L-tyrosine and norepinephrine in CRS group, accompanied with downregulation of homovanillic acid. Focusing on these altered metabolic pathways in EC, we found that gene levels of GAD1, GLUL and SNAT1 were increased. Upregulation of SERT and EAAT2 in protein expression level were also validated, while no significant changes were found in TH, AADC, MAOA, VMAT2, GAD1, GLUL and SNAT1. Our findings firstly provide evidence about the alteration of metabolites and related molecules in the EC of mice model of depression, implying the potential mechanism in MDD pathology.
Hippocampal mRNA expression profiling in mice exposed to chronic unpredictable mild stress

Yanlin Tao,Zhejun Xie,Jiachen Shi,Rongliwen Ou,Hui Wu,Hailian Shi,Fei Huang,Xiaojun Wu

DOI: https://doi.org/10.1016/j.brainresbull.2020.06.001

IF: 3.715

2020-09-01

Brain Research Bulletin

Abstract:<p>Depression is a state of low mood and aversion to activity, affecting a person's thoughts, behavior, motivation, feelings and sense of well-being, which is associated with dramatical gene expression changes in hippocampus. Rodents induced by chronic unpredictable mild stress (CUMS) demonstrate typical depression-like behaviors similar to clinical patients, therefore, are commonly used as a model for depression and antidepressant study. In order to enhance our understanding of the molecular mechanisms of the pathogenesis of depression, in the present study, the hippocampal mRNA expression profile of mice exposed to CUMS for 5 weeks was sequenced using Illumina HiSeq 4000 platform followed by enrichment analysis, including Hierarchical Cluster, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and protein-protein interaction (PPI) network. Totally, 346 differently expressed mRNAs, including 208 downregulated and 138 upregulated, were identified in the hippocampus of the CUMS mice. KEGG biological pathway analysis showed that the upregulated and downregulated mRNAs were mostly enriched in 29 pathways and 8 pathways, respectively. PPI network analysis exposed that glyceraldehyde 3-phosphate dehydrogenase was the crucial node with high connectivity degree. Additionally, most of these genes in PPI network analysis which have previously been linked to energy metabolism and corticosterone responses. Overall, our results indicate the possible novel molecular targets for the therapy of depression.</p>

neurosciences
Identification of Potential Biomarkers for Major Depressive Disorder: Based on Integrated Bioinformatics and Clinical Validation

Xiaogang Zhong,Yue Chen,Weiyi Chen,Yiyun Liu,Siwen Gui,Juncai Pu,Dongfang Wang,Yong He,Xiang Chen,Xiaopeng Chen,Renjie Qiao,Peng Xie

DOI: https://doi.org/10.1007/s12035-024-04217-1

2024-05-09

Abstract:Major depressive disorder (MDD) is a severe mental illness characterized by a lack of objective biomarkers. Mounting evidence suggests there are extensive transcriptional molecular changes in the prefrontal cortex (PFC) of individuals with MDD. However, it remains unclear whether there are specific genes that are consistently altered and possess diagnostic power. In this study, we conducted a systematic search of PFC datasets of MDD patients from the Gene Expression Omnibus database. We calculated the differential expression of genes (DEGs) and identified robust DEGs using the RRA and MetaDE methods. Furthermore, we validated the consistently altered genes and assessed their diagnostic power through enzyme-linked immunosorbent assay experiments in our clinical blood cohort. Additionally, we evaluated the diagnostic power of hub DEGs in independent public blood datasets. We obtained eight PFC datasets, comprising 158 MDD patients and 263 healthy controls, and identified a total of 1468 unique DEGs. Through integrated analysis, we identified 290 robustly altered DEGs. Among these, seven hub DEGs (SLC1A3, PON2, AQP1, EFEMP1, GJA1, CENPD, HSD11B1) were significantly down-regulated at the protein level in our clinical blood cohort. Moreover, these hub DEGs exhibited a negative correlation with the Hamilton Depression Scale score (P < 0.05). Furthermore, these hub DEGs formed a panel with promising diagnostic power in three independent public blood datasets (average AUCs of 0.85) and our clinical blood cohort (AUC of 0.92). The biomarker panel composed of these genes demonstrated promising diagnostic efficacy for MDD and serves as a useful tool for its diagnosis.
[Bioinformatics analysis of genes related to pathogenesis of major depression disorder]

Li-Juan Gao,Xin Zhao,Jian-Guo Li,Yong Xu,Yu Zhang

2018-08-25

Abstract:The aim of this study was to screen the genes related to the pathogenesis of major depression disorder (MDD) by bioinformatics. Taking GSE98793 chip data from GEO public database of National Biotechnology Information Center (NCBI) website as the research object, 116 differentially expressed genes (DEGs) were screened by R language limma package. Among the 116 DEGs, 66 genes were up-regulated and 50 down-regulated. The results of gene functional annotation analysis of Gene Ontology (GO) showed that the DEGs were mainly distributed in mitochondria intima and mitochondria. They were involved in copper ion binding, cysteine-type endopeptidase activity, the cell response of interleukin-1, protein processing and other biological processes. KEGG pathway enrichment analysis results showed that the DEGs were mainly concentrated in oxidative phosphorylation, Parkinson's disease, non-alcoholic fatty liver disease, Alzheimer's disease and Huntington's disease etc. The results of protein interaction network analysis showed that there were interactions among proteins encoded by 54 DEGs. Combined with the analysis results of the above methods, 11 key genes were screened out, including UQCRC1, GZMB, NDUFB9, NSF, SLC17A5, CTSH, NDUFB10, UQCR10, ATOX1, CST7 and CTSW, which could be used as candidate genes for the diagnosis and treatment of MDD. Taken together, the key genes were obtained by analyzing the microarray and the DEGs of MDD in the present study, which would provide important clues for revealing the molecular mechanism and clinical targeted therapy of depression.
Sulfated glycoconjugates demonstrated in combination with high iron diamine thiocarbohydrazide-silver proteinate and silver acetate physical development.

F. Murata,S. Tsuyama,K. Ihida,N. Kashio,M. Kawano,Z. Z. Li

DOI: https://doi.org/10.1093/oxfordjournals.jmicro.a050925

1992-02-01

Journal of Electron Microscopy

Abstract:Sulfated glycoconjugates in epithelial cells and mesenchymal cells were investigated after staining with high iron diamine-thiocarbohydrazide-silver proteinate. One purpose of the experiment was to apply a new physical developed to the staining. Instead of silver nitrate, silver lactate or silver bromide, we used silver acetate as an ion donor. This new method allowed physical development under normal lighting conditions, and resulted in the reduction of background staining even after amplification. As the developer did not contain gum arabic, troublesome treatment was not necessary. The time required for staining was very short and the electron density of the final reaction product was high and easily identifiable under the electron microscope. Fixing was not necessary. Very small amounts of reactive substance were detectable after physical development. This developmental procedure has been applied to both the preembedding staining and postembedding staining of sulfated glycoconjugates. The results obtained using this method are presented.
Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder

Jie Qiao

2015-01-01

Chinese Science Bulletin

Abstract:Major depressive disorder(MDD), a polygenic disease resulting from complicated interactions between environmental and genetic factors, is becoming an increasingly serious threat to global public health. Genome-wide gene expression analysis is widely used for psychiatric disorders because of its ability to detect spatio-temporal patterns of gene expression. However, it is difficult to elucidate the molecular mechanism of MDD by methods that analyze brain regions and/or genes individually because activation patterns may differ between brain regions and MDD may be regulated by multiple genes with moderate or weak effects. In this study, we used a strategy that leverages information across multiple brain regions and genes. We performed gene set enrichment analysis of transcriptomics data from different brain regions of MDD patients and health controls in 13 datasets from the Gene Expression Omnibus. Our results show that the neuron markers gene set was significantly down-regulated in the associative striatum, anterior cingulate cortex(ACC), and amygdala, which is consistent with current MDD knowledge. The gene expression of glial cell markers was also altered in MDD patients, but there were no consistent patterns across brain regions or datasets from the same region. Moreover, gender-specific activation patterns of the astrocyte markers and oligodendrocyte markers gene sets were observed in the ACC and amygdala. In a comparative analysis of psychiatric disorders, the neuron markers gene set were also significantly down-regulated in multiple brain regions of patients with bipolar disorder and schizophrenia, although the activation patterns of two glial cell markers gene sets and the choroid plexus markers gene set in these two disorders differed from that of MDD. Our results reveal potential candidate brain regions, gene sets, and genes that are altered in MDD.

Introduction to the Symposium on bistable and sensitizing pigments in vision

The Protective Role Of Neuregulin1-Erbb4 Signaling In A Chronic Social Defeat Stress Model

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).

Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress

Identification of Major Depressive Disorder Disease-Related Genes and Functional Pathways Based on System Dynamic Changes of Network Connectivity.

Transcriptome comparative analysis of amygdala-hippocampus in depression: A rat model induced by chronic unpredictable mild stress (CUMS)

Identification of Key Genes and the Pathophysiology Associated with Major Depressive Disorder Patients Based on Integrated Bioinformatics Analysis

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.

Identification and Analyses of Crucial Genes Associated with Pathogenesis of Major Depressive Disorder

NMR stray-field analysis of oil drop size distribution in peanut cotyledons

Comprehensive analysis of endoplasmic reticulum stress and immune infiltration in major depressive disorder

Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex

Comparative transcriptional analyses of the striatum in the chronic social defeat stress model in C57BL/6J male mice and the gut microbiota-dysbiosis model in Kumming mice

Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis

Entorhinal cortex-based metabolic profiling of chronic restraint stress mice model of depression

Hippocampal mRNA expression profiling in mice exposed to chronic unpredictable mild stress

Identification of Potential Biomarkers for Major Depressive Disorder: Based on Integrated Bioinformatics and Clinical Validation

[Bioinformatics analysis of genes related to pathogenesis of major depression disorder]

Sulfated glycoconjugates demonstrated in combination with high iron diamine thiocarbohydrazide-silver proteinate and silver acetate physical development.

Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder